Physician profile

Bradley John Cheek

Anatomic Pathology & Clinical Pathology · Las Vegas, NV

NPI 1275774242

$328.06

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

See the full distribution for Anatomic Pathology & Clinical Pathology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$19.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alexion Pharmaceuticals, INC. $104.53 2019
Novartis Pharmaceuticals Corporation $47.10 2019
Novo Nordisk INC $46.81 2019
Servier Pharmaceuticals LLC $44.27 2019-2020
Sobi, INC $25.56 2019
Inspire Medical Systems, INC. $19.89 2023 Inspire
Jazz Pharmaceuticals INC. $14.65 2019
Bayer Healthcare Pharmaceuticals INC. $13.54 2019
Takeda Pharmaceuticals U.S.A., INC. $11.71 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bradley John Cheek

$328.06

in general payments reported 2019-2025

Years
2019-2023
Top company
Alexion Pharmaceuticals, INC.

https://glasscript.com/doctor/238993/bradley-john-cheek

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.